Institutional & Family Asset Management, LLC Gilead Sciences, Inc. Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

A detailed history of Institutional & Family Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Institutional & Family Asset Management, LLC holds 2,084 shares of GILD stock, worth $148,318. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,084

Previous 1,417 47.07%

Holding current value

$148,318

Previous $103,000 37.86%

% of portfolio

0.02%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	BUY	$63.15 - $72.88 $42,121 - $48,610	667 Added 47.07%	2,084 $142,000
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $6,012 - $7,332	-84 Reduced 5.6%	1,417 $103,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $10,351 - $11,293	140 Added 10.29%	1,501 $112,000
Q2 2023 Aug 09, 2023	BUY	$76.01 - $86.7 $2,052 - $2,340	27 Added 2.02%	1,361 $104,000
Q1 2023 May 08, 2023	BUY	$77.31 - $88.08 $22,961 - $26,159	297 Added 28.64%	1,334 $110,000

Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $8,475 - $12,167	-136 Reduced 11.59%	1,037 $89,000
Q3 2022 Nov 07, 2022	SELL	$59.54 - $68.01 $22,387 - $25,571	-376 Reduced 24.27%	1,173 $72,000
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $577 - $650	10 Added 0.65%	1,549 $96,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $259 - $294	-4 Reduced 0.26%	1,539 $112,000
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $37,500 - $40,458	554 Added 56.02%	1,543 $108,000
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $10,140 - $11,569	169 Added 20.61%	989 $64,000
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $2,152 - $2,452	-38 Reduced 4.43%	820 $48,000
Q3 2020 Oct 30, 2020	SELL	$62.1 - $78.08 $5,402 - $6,792	-87 Reduced 9.21%	858 $54,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $29,297 - $34,020	-405 Reduced 30.0%	945 $73,000
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $2,818 - $3,609	-45 Reduced 3.23%	1,350 $101,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $4,128 - $4,541	-67 Reduced 4.58%	1,395 $91,000
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $15,252 - $16,836	-244 Reduced 14.3%	1,462 $93,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $105,302 - $118,084	1,702 Added 42550.0%	1,706 $115,000
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $4,282 - $4,994	-66 Reduced 94.29%	4 $0
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $5,098 - $6,216	70 New	70 $5,000

Others Institutions Holding GILD

# of Institutions

1,890

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $89.2B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account

Institutional & Family Asset Management, LLC Gilead Sciences, Inc. Transaction History